Cargando…
Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
5-Hydroxytryptamine type 2 antagonists are used to treat symptomatic peripheral arterial disease. However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Japan
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085500/ https://www.ncbi.nlm.nih.gov/pubmed/23494607 http://dx.doi.org/10.1007/s00380-013-0334-1 |